AIDS Clinical Trials Group Network
AIDS Clinical Trials Group Network
批准号:
7492221
负责人:
CONSTANCE ANN BENSON
金额:
$3689.01万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-29 至 2013-05-31
关键词:
AIDS clinical trial groupAIDS-Related Opportunistic InfectionsAcquired Immunodeficiency SyndromeAddressAdherenceAdolescentAfricaAlabamaAllelesAmendmentAntigen-Presenting CellsAntiviral AgentsAreaArtsAsiaAwardBackBiologicalBiological AssayBiological ProductsBiomedical ResearchBloodBlood specimenBostonBuffaloesCD8B1 geneCaliforniaCaribbean nativesCaribbean regionCaringCell physiologyCellsCerebrospinal FluidCervicalCharacteristicsChildhoodClinicalClinical ManagementClinical PharmacologyClinical ResearchClinical TrialsClinical Trials NetworkClinical trial protocol documentCollaborationsColoradoCommittee MembersCompetenceComplementary DNAComplexConditionConsensusContractsCoombs&apos TestCountryCritiquesCytomegalovirusDNADataData AnalysesDendritic CellsDentalDepthDetectionDevelopmentDisciplineDisease ProgressionDoctor of MedicineDoctor of PhilosophyDoseDrug EvaluationDrug ExposureDrug InteractionsDrug KineticsDrug MonitoringDrug resistanceEnd PointEnsureEpidemicEquipmentEquipment and supply inventoriesEscape MutantEvaluationExhibitsFreezingFrequenciesFundingGenderGene TargetingGeneral HospitalsGenesGenital systemGenomicsGenotypeGoalsGrowthHIVHIV InfectionsHIV prevention trials networkHIV vaccineHIV-1HIV-1 drug resistanceHIV-1 proteaseHIV-1 vaccineHeadHealth SciencesHealth Services ResearchHepatitis BHepatitis B VirusHepatitis CHepatitis C virusHepatitis VirusesHumanHuman Herpesvirus 8Human ResourcesImmuneImmune responseImmunityImmunizationImmunologic MarkersImmunologic MonitoringImmunologicsImmunologistImmunologyImmunotherapeutic agentImmunotherapyIn VitroIndividualIndustryInfectionInflammatoryInformaticsInstitutesInternationalInternational Maternal Pediatric Adolescent AIDS Clinical Trials GroupInterventionInvestigationIsraelKnowledgeLaboratoriesLaboratory ResearchLatin AmericaLeadershipLengthLigationLinkLiverLiver diseasesLymphoidMalariaMassachusettsMeasurementMeasuresMedical centerMethodsMicrobicide Trials NetworkMinorMinorityMissionModelingMolecular CloningMonitorMorbidity - disease rateMulti-Drug ResistanceMutationMycobacterium InfectionsNNRTI-resistanceNatural ImmunityNeuraxisNew YorkOligonucleotidesOperative Surgical ProceduresOral healthOther TherapyOutcomePathogenesisPathway interactionsPatientsPeer ReviewPerformancePeripheral Blood Mononuclear CellPersonsPharmaceutical PreparationsPharmacogenomicsPharmacologyPharmacology, OtherPhasePhenotypePhylogenetic AnalysisPlasmaPlayPolymerasePolymerase Chain ReactionPopulationPredispositionPregnant WomenPreventionPrincipal InvestigatorProceduresProcessProductivityProtease InhibitorProtein BindingProtocols documentationPublicationsPublishingPurposeQualifyingQuality ControlRNARNA-Directed DNA PolymeraseRangeRecombinantsRecoveryReference StandardsRelative (related person)ReportingResearchResearch ActivityResearch DesignResearch InfrastructureResearch InstituteResearch PersonnelResearch PriorityResistanceResource SharingResourcesReverse Transcriptase Polymerase Chain ReactionRoleSafetySamplingSan FranciscoScienceScientistSelection CriteriaSeminal fluidServicesSex CharacteristicsSilverSiteSite-Directed MutagenesisSpecimenStandards of Weights and MeasuresStatistical Data InterpretationStructureSurveysSystemTalentsTechnical ExpertiseTechniquesTechnologyTechnology TransferTestingTherapeuticTherapeutic AgentsTherapeutic Clinical TrialTherapy Clinical TrialsTimeTissuesTotal Quality ManagementTraining ProgramsTranslatingTranslational ResearchTranslationsTreatment FailureTreatment ProtocolsTreatment outcomeTuberculosisUnited StatesUnited States National Institutes of HealthUniversitiesVaccinationVaccine ResearchVaccinesValidationVariantVertical Disease TransmissionVictoria AustrailiaViralViral PathogenesisViral hepatitisViremiaVirusVirus ReplicationWashingtonWomanWorkabstractinganalytical methodantiretroviral therapyassay developmentbasebench to bedsideclinical research siteclinically relevantconceptcostcraniofacialdata managementdata modelingdesigndrug developmentexperiencefitnessgenome sequencingimmune functionimprovedin vivoinnovationinterestintrahepatickiller T celllymph nodesmedical schoolsmedical specialtiesmembermodels and simulationmortalitynovelnovel therapeuticsonline tutorialoral HIVorganizational structurepathogenpeerpharmacokinetic modelpreventprogramsquality assurancereconstitutionrepositoryresearch and developmentresistance mechanismresponserestorationskillssocialstatisticssuccesstherapeutic vaccinetreatment trialtripolyphosphatevaccination strategyvirologyvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The mission of the AIDS Clinical Trials Group (ACTG) is to develop and conduct scientifically rigorous translational research and therapeutic clinical trials to: 1) investigate the viral and immune pathogenesis of HIV-1 infection and its complications; 2) evaluate novel therapeutic agents and the most effective approaches and strategies for the use of existing agents to treat HIV-1 infection; 3) evaluate interventions and strategies to treat and prevent HIV-related opportunistic infections, co-infections, complications of therapies, and other HIV-1-related co-morbidities, and 4) publish and disseminate the findings from these studies for the purpose of improving clinical care, preventing or delaying HIV disease progression, and reducing or eliminating the morbidity and mortality associated with HIV-1 infection and its associated complications. In this application the ACTG proposes a comprehensive, integrated clinical and translational research program that addresses five of the six scientific areas outlined under this RFA: 1) Translational Research and Drug Development; 2) Optimization of Clinical Management, including Co-Infection; 3) Vaccine Research and Development; 4) Prevention of Mother to Child Transmission, and 5) Prevention of HIV Infection. An Oral Health program will be undertaken in collaboration with investigators supported by the National Institute of Dental and Craniofacial Research. This program will be conducted in collaboration with the HIV Prevention Trials Network (HPTN), the HIV Vaccine Trials Network (HPTN), the IMPAACT network and the Microbicide Trials Network (MTN). The proposed research agenda as well as the Group Leadership and organizational structure reflect the worldwide impact of the HIV epidemic. We propose to conduct the work using a network of 72 clinical research sites in the United States and 12 countries in Africa, Asia, Latin America and the Caribbean. The network is actively supported by an integrated network of Core Laboratories with broad expertise in virology, pharmacology, immunology, and genomics. The ACTG Operations Center, located in Silver Spring, MD, provides key operational, administrative, and fiscal support. Statistical expertise and data management resources are provided by the Statistics and Data Management Center in Boston, MA and Buffalo, NY.
CORE (P.I. Benson, Constance)
CORE: Translational Research/Drug Development
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients
-
批准号:10166377
-
项目类别:
-
资助金额:$84.56万
-
财政年份:2020
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
-
批准号:9319811
-
项目类别:
-
资助金额:$95.55万
-
财政年份:2015
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
A Novel Wireless Ingestible Sensor System for Measurement of medication Adherence in HIV Treatment and Prevention
-
批准号:9411660
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2015
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
-
批准号:9040412
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2015
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
-
批准号:9751389
-
项目类别:
-
资助金额:$68.83万
-
财政年份:2015
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
-
批准号:9145781
-
项目类别:
-
资助金额:$98.01万
-
财政年份:2015
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
CLINICAL TRIAL: ADULT AIDS CLINICAL TRIALS GROUP LONGITUDINAL LINKED RANDOMIZED
-
批准号:8166818
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2009
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
AIDS Clinical Trials Group Network
-
批准号:7923515
-
项目类别:
-
资助金额:$113.09万
-
财政年份:2009
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
-
批准号:7994193
-
项目类别:
-
资助金额:$464.62万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
The UCSD CD4 Collaborative Clinical Trial Unit
-
批准号:9179576
-
项目类别:
-
资助金额:$237.0万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Collaborative Clinical Trials Unit
-
批准号:10304895
-
项目类别:
-
资助金额:$362.34万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
-
批准号:7345449
-
项目类别:
-
资助金额:$312.15万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
-
批准号:7095762
-
项目类别:
-
资助金额:$203.7万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
-
批准号:8392953
-
项目类别:
-
资助金额:$319.29万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
The UCSD CD4 Collaborative Clinical Trial Unit
-
批准号:8784154
-
项目类别:
-
资助金额:$10.33万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Collaborative Clinical Trials Unit
-
批准号:10057305
-
项目类别:
-
资助金额:$363.45万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
-
批准号:7742604
-
项目类别:
-
资助金额:$475.43万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Collaborative Clinical Trials Unit
-
批准号:10531580
-
项目类别:
-
资助金额:$323.47万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
-
批准号:8197334
-
项目类别:
-
资助金额:$291.91万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
-
批准号:7572947
-
项目类别:
-
资助金额:$475.8万
-
财政年份:2007
-
负责人:CONSTANCE ANN BENSON
-
依托单位:
海外基金